Research ExplorerJournalsNAT CANCER Publications

NAT CANCER - Nature Cancer

1 - 4 out of 4Page size: 50

Publications

  1. 2023

  2. Anti-SARS-CoV-2 antibody-containing plasma improves outcome in patients with hematologic or solid cancer and severe COVID-19: a randomized clinical trial

    Denkinger, C. M., Janssen, M., Schäkel, U., Gall, J., Leo, A., Stelmach, P., Weber, S. F., Krisam, J., Baumann, L., Stermann, J., Merle, U., Weigand, M. A., Nusshag, C., Bullinger, L., Schrezenmeier, J-F., Bornhäuser, M., Alakel, N., Witzke, O., Wolf, T., Vehreschild, M. J. G. T., Schmiedel, S., Addo, M. M., Herth, F., Kreuter, M., Tepasse, P-R., Hertenstein, B., Hänel, M., Morgner, A., Kiehl, M., Hopfer, O., Wattad, M-A., Schimanski, C. C., Celik, C., Pohle, T., Ruhe, M., Kern, W. V., Schmitt, A., Lorenz, H-M., Souto-Carneiro, M., Gaeddert, M., Halama, N., Meuer, S., Kräusslich, H-G., Müller, B., Schnitzler, P., Parthé, S., Bartenschlager, R., Gronkowski, M., Klemmer, J., Schmitt, M., Dreger, P., Kriegsmann, K., Schlenk, R. F. & Müller-Tidow, C., 01.2023, In: NAT CANCER. 4, 1, p. 96-107 12 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  3. 2022

  4. Transition to a mesenchymal state in neuroblastoma confers resistance to anti-GD2 antibody via reduced expression of ST8SIA1

    Mabe, N. W., Huang, M., Dalton, G. N., Alexe, G., Schaefer, D. A., Geraghty, A. C., Robichaud, A. L., Conway, A. S., Khalid, D., Mader, M. M., Belk, J. A., Ross, K. N., Sheffer, M., Linde, M. H., Ly, N., Yao, W., Rotiroti, M. C., Smith, B. A. H., Wernig, M., Bertozzi, C. R., Monje, M., Mitsiades, C. S., Majeti, R., Satpathy, A. T., Stegmaier, K. & Majzner, R. G., 08.2022, In: NAT CANCER. 3, 8, p. 976-993 18 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  5. Potent suppression of neuroendocrine tumors and gastrointestinal cancers by CDH17CAR T cells without toxicity to normal tissues

    Feng, Z., He, X., Zhang, X., Wu, Y., Xing, B., Knowles, A., Shan, Q., Miller, S., Hojnacki, T., Ma, J., Katona, B. W., Gade, T. P. F., Schrader, J., Metz, D. C., June, C. H. & Hua, X., 05.2022, In: NAT CANCER. 3, 5, p. 581-594 14 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  6. 2021

  7. Tryptophan metabolism drives dynamic immunosuppressive myeloid states in IDH-mutant gliomas

    Friedrich, M., Sankowski, R., Bunse, L., Kilian, M., Green, E., Ramallo Guevara, C., Pusch, S., Poschet, G., Sanghvi, K., Hahn, M., Bunse, T., Münch, P., Gegner, H., Sonner, J., von Landenberg, A., Cichon, F., Aslan, K., Trobisch, T., Schirmer, L., Abu-Sammour, D., Kessler, T., Ratliff, M., Schrimpf, D., Sahm, F., Hopf, C., Heiland, D., Schnell, O., Beck, J., Böttcher, C., Fernandez-Zapata, C., Priller, J., Heiland, S., Gutcher, I., Quintana, F., von Deimling, A., Wick, W., Prinz, M. & Platten, M., 24.05.2021, In: NAT CANCER. 2, p. 723-740

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review